BioAmp Diagnostics, Inc.
Medtech · Private
Biochemical assay (DETECT technology) for rapid detection and classification of carbapenem-resistant organisms with carbapenemase enzymes, integrated into automated antibiotic susceptibility testing s
bioampdiagnostics.com →- Grants
- $1.7M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Development of point-of-care diagnostics to direct the appropriate use of antibiotics for the treatment of high-risk urinary tract infections | $224,996 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II:Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections | $1,199,998 | |
| Federal grant | Department of Health and Human Services · Phase I · Evolving the standard of care for carbapenem resistant infections, through the development of a phenotypic assay capable of DETECTing and classifying carbapenemases | $243,806 | |
| Federal grant | Department of Health and Human Services · Phase I · Evolving the standard of care for carbapenem resistant infections, through the development of a phenotypic assay capable of DETECTing and classifying carbapenemases | $79,309 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1257 | Bone Health Technologies, Inc. | — | $3.7M |
| 1258 | H2OPTX | — | — |
| 1259 | Tector, Inc. | — | — |
| 1260 | BioAmp Diagnostics, Inc. | — | — |
| 1261 | Innerspec Technologies Inc | — | — |
| 1262 | DeVoro Medical Inc. | — | $26M |
| 1263 | Naveris, Inc. | — | $34M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Rapid Diagnostic Dry Reagent Test For Antibiotic Resistance, And Methods Of Use And Methods Of Making Thereofapplication
- Rapid Diagnostic Test For Antibiotic Resistance, And Methods Of Use And Methods Of Making Thereofapplication
- Rapid Diagnostic Dry Reagent Test For Antibiotic Resistance, And Methods Of Use And Methods Of Making Thereofapplication
- Compounds To Identify Beta-lactamases, And Methods Of Use Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.